Skip to main content

Table 3 Body morphomics changes

From: Investigating the clinical significance of body composition changes in patients undergoing chemoradiation for oropharyngeal cancer using analytic morphomics

Characteristics (N = 43)

Pre-treatment

Mean (SD)

Post-treatment

Mean (SD)

Percent change (95 % CI)

P value

Weight (kg)

92 ±17

82 ± 15

−10.33 (−8.05, −12.61)

<0.001

Body mass index (BMI)*

29.1 ± 5

26.7 ± 4.2

−9.71 (−7.41, −12.01)

<0.001

 Normal (N = 8)

23.2 ± 1.14

21.2 ± 2.89

−8.62 (−5.6, −11.64)

<0.05

 Overweight (N = 16)

28.20 ± 1.41

25.72 ± 2.03

−8.79 (−7.39, −10.19)

<0.001

 Obese (N = 19)

34.71 ± 3.18

29.86 ± 3.03

−13.97 (−11.7, −16.24)

<0.001

Bone Marrow Density (L4)

159 ± 42.1

159 ± 41.3

0

Total psoas area (mm2)

2811 ± 726

2492 ± 626

−10.88 (−8.70, −13.06)

<0.001

Left psoas area (mm2)

1407 ± 356

1244 ± 311

−10.75 (−7.73, −13.77)

<0.001

Right psoas area (mm2)

1404 ± 385

1248 ± 328

−10.74 (−8.45, −13.03)

<0.001

Psoas density (HU)

52.0 ± 7.1

47.2 ± 7.9

−9.16 (−4.42, −13.9)

<0.005

Lean psoas (HU × mm2)

1130 ± 300

973 ± 270

−14.09 (−11.07, −17.01)

<0.001

  1. Changes in body morphomics measures were assessed from pre-treatment to 3 months post-up
  2. * BMI categories of normal (18.5–24.9), overweight (25–29.9) and obese (≥30) were used to stratify the cohort